MHRA Safety Roundup: May 2025

The Commission on Human Medicines (CHM) has temporarily restricted use of the IXCHIQ Chikungunya vaccine in people aged 65 years and over following very rare fatal reactions reported globally. This is a precautionary measure while the MHRA conducts a safety review. The IXCHIQ vaccine will be available on the UK market from 18 June 2025.

Summary of the latest safety advice for medicines and medical device users

The MHRA is inviting the next generation of doctors to explore how genetics could improve prescribing and patient safety in the UK.

MHRA strikes massive blow to organised criminal gang in world’s biggest illegal weight loss jabs raid.

This holiday season, the MHRA is reminding people that some common festive foods can interact with medicines, altering how well they work or increasing the risk of side effects.

The call for applications for phase 2 of the AI Airlock is now closed.